Skip to main content
NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%NVDA-0.82%AAPL+0.91%GOOGL-2.28%MSFT-0.15%AMZN+0.01%TSM-0.83%SPCX-3.86%AVGO-1.13%META+0.43%TSLA-1.41%SKHY+7.05%MU-2.00%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.20%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-1.52%0005.HK-0.78%HSBA.L-1.48%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.19%CHFJPY-1.57%AUDJPY-1.53%USDJPY-1.32%EURJPY-1.29%GBPJPY-1.24%CADJPY-1.17%NZDCAD-1.04%GBPNZD+0.95%EURNZD+0.93%NZDUSD-0.90%USDNOK+0.70%AUDNZD+0.69%NZDCHF-0.66%USDZAR+0.58%EURNOK+0.54%USDSEK+0.49%CHFNOK+0.49%EURZAR+0.44%GBPZAR+0.43%GBPTRY+0.41%AUDCAD-0.38%CADCHF+0.38%EURSEK+0.34%GBPHKD+0.32%GBPCHF+0.31%USDTHB+0.30%USDPLN+0.29%GBPMXN-0.28%CHFSEK+0.28%AUDNOK+0.28%NOKJPY-0.28%GBPAUD+0.27%EURCHF+0.27%AUDDKK-0.27%USDCHF+0.26%SGDJPY+0.26%AUDSGD-0.25%EURAUD+0.24%USDMXN+0.23%AUDUSD-0.22%EURHKD-0.16%USDSGD+0.16%USDILS+0.16%USDDKK+0.15%EURPLN+0.14%USDCAD-0.13%EURCAD-0.13%PLNJPY+0.12%USDTRY+0.11%EURCNH-0.11%GBPCAD-0.09%GBPUSD+0.07%EURCZK-0.07%CHFSGD-0.05%NZDMXN+0.04%AUDCHF+0.04%USDCOP-0.04%EURGBP-0.03%USDCNH+0.02%EURUSD+0.02%EURSGD+0.01%USDHKD+0.01%NZDSGD-0.01%EURDKK0.00%GBPSGD0.00%HG1-4.14%XPTUSD-3.57%COFFEE-2.51%XAGUSD-2.50%GAGUSD-2.50%SUGAR+2.02%USOIL+1.91%UKOIL+1.87%COCOA-1.11%COTTON+0.84%C1+0.76%S1+0.75%BTCUSD-0.64%ETHUSD-0.36%USDTUSD-0.04%XRPUSD-1.35%SOLUSD-0.47%TRXUSDT+0.45%ZECUSDT-2.14%DOGEUSD-1.16%XMRUSDT-1.11%LINKUSD+0.14%XLMUSD-0.97%BCHUSDT-2.64%LTCUSD-1.86%UNIUSD-2.16%TONUSD+24.88%HBARUSDT-1.07%SUIUSD-1.42%TAOUSDT-1.32%AAVEUSD-2.27%DOTUSDT-2.36%ICPUSDT-1.04%ONDOUSDT-2.01%WLDUSDT-1.71%ATOMUSDT-3.30%ARBUSDT-0.98%JUPUSDT-2.53%INJUSDT-2.31%STXUSDT-2.34%FETUSDT-2.68%TIAUSDT-0.34%PYTHUSDT-0.46%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-2.93%GRTUSDT-3.07%OPUSDT-0.99%POLUSDT-5.30%IOTAUSDT-2.98%AXSUSDT-1.82%FARTCOINUSDT-2.90%EOSUSDT-0.06%DYDXUSDT+0.65%ORDIUSDT-0.28%GALAUSDT-2.53%NOTUSDT-0.68%RONINUSDT-0.71%
SS

STAAR Surgical Company (STAA)

NASDAQ • Healthcare

$23.62
-$0.53 (-2.2%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$23.9
Day Range$23.37 - $24.27
Avg. Volume (3M)936.1K
Market Cap$1.1B
P/E Ratio295.3
52 Week Range
$15.59$35.87
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$93.5M100%
Gross Profitminus cost of goods$69.7M75%
Operating Incomeminus R&D and overhead$10.1M11%
Net Incomeminus taxes and the rest$8M9%

In plain terms: out of every $100 in revenue, STAAR Surgical Company keeps $9 as net profit.

Fundamentals & Financials

Revenue (TTM)
$339.5M
Net Income (TTM)
$3.8M
EPS (TTM)
$0.08
ROA (TTM)
0.81%
Current Ratio
4.66
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-211.1%Q1 2026-$0.2
+600.8%Q2 2026$0.38
-27.7%Q3 2026$0.16
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -27.7%

STAAR Surgical’s second fiscal quarter of 2026 paired a revenue beat with an EPS miss, as results reported August 12, 2026 showed revenue of $93.5 million topped the $90.6 million estimate (+3.2%) while EPS of $0.16 trailed the $0.22 estimate (-28%). Revenue rose 111% to about $93.5 million, up from about $44.3 million a year ago, alongside a swing in per-share results from -$0.34 a year ago. Profitability came through at a gross margin of roughly 75% and an operating margin near 11%, with gross profit of about $69.7 million and operating income of roughly $10.1 million. The quarter generated operating cash flow of about $19.7 million, and the company repurchased roughly $2.7 million of stock. For the next period, consensus calls for EPS of $0.20 on revenue of $79.1 million.

View full earnings history

About STAAR Surgical Company

STAAR Surgical Company develops, manufactures, and commercializes ophthalmic devices centered on implantable lenses for vision correction, sells products used by eye-care providers across cataract and refractive procedures, and trades on the NASDAQ under STAA in the healthcare equipment and medical supplies business. In FY2025, the company generated $239.4 million in revenue.

Name
STAAR Surgical Company
CEO
Warren Foust
Website
www.staar.com
Industry
Healthcare
Year Founded
1982
Employees
921

Today's Snapshot

AI-generated

STAA closed 2.2% lower at 23.62. STAAR Surgical reappointed David Bailey, its chief executive, to lead growth.

Trading Volume

Below 10d avg (843.8K)

824.5K

vs S&P 500 Today

Underperforming Market

-1.76%

Updated: September 10, 2026 at 12:10 UTC

Technical Indicators

1 Buy3 Neutral4 Sell
STAA reads as cautious to negative: the stock is below several medium- and longer-term moving averages, including most of the 50- to 200-period series, while short-term averages sit slightly below price, signaling recent weakness. Momentum indicators are mostly neutral and ADX shows a lack of directional conviction, but on-balance volume is weak, which supports the bearish tilt. Volatility is moderate and the pivot is near the current level, offering limited near-term guidance. Technical takeaway: Sell — price sits beneath key medium/long moving-average resistance with weak volume and muted trend strength.
All signals
  • EMA (5 indicators)$23.47 - $25.16
    Sell
  • RSI (14)47.89
    Neutral
  • Stochastic %K (14, 3, 3)56.67
    Neutral
  • MACD Level (12, 26)-0.39
    Neutral

Peers & Related Assets

PLSEPulse Biosciences, Inc.
$52.97+8.6%
PGENPrecigen, Inc.
$6.8-1.0%
NVCRNovocure Ltd
$15.63-7.2%
BLFSBioLife Solutions, Inc.
$34.93-1.3%
KMTSKestra Medical Technologies, Ltd.
$24.07-6.1%
AZTAAzenta, Inc.
$30.15-2.2%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.